brexucabtagene autoleucel,Obecabtagene autoleucel
Autolus,GILEAD
['brexu-cel', 'leusm']
#asco23 #leusm faramand: fair question about obe-cel durability at this point, but median followup still &lt;1yr. most important signal now is reduced toxicity w obe-cel wo apparently compromising response rate. durability will be the key in c/w brexu-cel which has set a high bar. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)